DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), today reported data at the American Association of Cancer Research (AACR) Annual Meeting 2015 demonstrating that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback